This topic contains a solution. Click here to go to the answer

Author Question: A patient has been taking paroxetine (Paxil) for major depressive symptoms for 8 months. The patient ... (Read 33 times)

arivle123

  • Hero Member
  • *****
  • Posts: 569
A patient has been taking paroxetine (Paxil) for major depressive symptoms for 8 months. The patient tells the primary care NP that these symptoms improved after 2 months of therapy.
 
  The patient is experiencing weight gain and sexual dysfunction and wants to know if the medication can be discontinued. The NP should: a. change to a tricyclic antidepressant medication.
  b. begin to taper the paroxetine and instruct the patient to call if symptoms increase.
  c. tell the patient to stop taking the medication and to call if symptoms get worse.
  d. continue the medication for several months and consider adding bupropion (Wellbutrin).

Question 2

A patient has been taking ciprofloxacin for 3 days and calls the primary care nurse practitioner (NP) to report having headaches and dizziness. The NP should:
 
  a. change to levofloxacin.
  b. decrease the dose of ciprofloxacin.
  c. change to an antibiotic in another drug class.
  d. reassure the patient that these are common side effects.



Related Topics

Need homework help now?

Ask unlimited questions for free

Ask a Question
Marked as best answer by a Subject Expert

scottmt

  • Sr. Member
  • ****
  • Posts: 322
Answer to Question 1

D
Once a patient achieves remission, a continuation phase of 16 to 20 weeks followed by a maintenance phase of 4 to 9 months should be carried out. Some responders, called apathetic responders, may have a decrease in most symptoms but continue to have lack of pleasure, decreased libido, and lack of energy. Bupropion can be added to therapy to treat these symptoms. Patients should not change medications during this phase, should not begin a drug taper, and should never stop the medication abruptly.

Answer to Question 2

D
Headaches and dizziness are common side effects of fluoroquinolones. It is not necessary to change to another fluoroquinolone, decrease the dose, or change to another antibiotic class.




arivle123

  • Member
  • Posts: 569
Reply 2 on: Jul 24, 2018
Gracias!


amit

  • Member
  • Posts: 364
Reply 3 on: Yesterday
YES! Correct, THANKS for helping me on my review

 

Did you know?

The Food and Drug Administration has approved Risperdal, an adult antipsychotic drug, for the symptomatic treatment of irritability in children and adolescents with autism. The approval is the first for the use of a drug to treat behaviors associated with autism in children. These behaviors are included under the general heading of irritability and include aggression, deliberate self-injury, and temper tantrums.

Did you know?

After 5 years of being diagnosed with rheumatoid arthritis, one every three patients will no longer be able to work.

Did you know?

Between 1999 and 2012, American adults with high total cholesterol decreased from 18.3% to 12.9%

Did you know?

Cutaneous mucormycosis is a rare fungal infection that has been fatal in at least 29% of cases, and in as many as 83% of cases, depending on the patient's health prior to infection. It has occurred often after natural disasters such as tornados, and early treatment is essential.

Did you know?

Amoebae are the simplest type of protozoans, and are characterized by a feeding and dividing trophozoite stage that moves by temporary extensions called pseudopodia or false feet.

For a complete list of videos, visit our video library